Pyxis Oncology Cash Flow Statement (2024-2025) | PYXS

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -4.00M-17.30M-21.20M-35.57M-21.67M-18.35M-22.00M
Share-based Compensation 4.32M2.87M2.98M2.77M3.63M3.02M3.07M
Gains from Investment Securities 6.89M6.96M12.23M
Non-cash Items 12.60M3.29M3.64M3.90M11.00M4.59M5.13M
Cash from Operations -20.71M-3.01M-14.66M-19.29M-22.54M-17.26M-13.28M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.29M1.64M1.65M1.53M1.16M0.90M0.53M
Depreciation & Amortization (CF) 1.12M0.58M0.73M0.55M0.55M0.54M0.53M
Change in Working Capital
Change in Receivables 8.00M
Change in Account Payables -1.36M3.18M-0.60M-0.01M-2.01M6.57M0.34M
Change in Accured Expenses -2.14M-0.81M3.97M-2.69M-1.31M-3.36M1.30M
Investing Activities
Capital Expenditures 0.24M
Cash from Investing Activities -18.50M0.00M-0.01M26.66M15.82M15.30M11.47M
Financing Activities
Change in Capital Stock
Shares Issued 0.24M0.05M0.00M
Misc.
Cash from Financing Activities 57.51M0.11M1.66M0.05M-0.01M
Change in Cash 18.30M-2.89M-13.02M7.42M-6.71M-2.03M-1.81M
Free Cash Flow -20.95M-3.01M-14.66M-19.29M-22.54M-17.26M-13.28M
Net Cash Flow 18.30M-2.89M-13.02M7.42M-6.71M-1.96M-1.81M